Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?

Peggy Gandia, Cécile Arellano, Thierry Lafont, Françoise Huguet, Laurence Malard, Étienne Chatelut

Cancer Chemotherapy and Pharmacology · 2012 · 31 citations · 21 references

Concepts

References

21